We're exiting a troubled drugmaker and putting the cash into 2 health-care stocks with brighter outlooks

  • 📰 CNBC
  • ⏱ Reading Time:
  • 19 sec. here
  • 13 min. at publisher
  • 📊 Quality Score:
  • News: 49%
  • Publisher: 72%

Breaking News: Markets News

Markets,Investment Strategy,Jim Cramer

These trades will boost the quality of our portfolio and create a slot for a new stock to join it.

We are exiting our position in Bausch Health , selling 2,930 shares at roughly $7.13. In addition, are buying 95 shares of Abbott Laboratories at roughly $104.53 and 125 shares of GE Healthcare at roughly $81. Following the trades, Jim Cramer's Charitable Trust will own 895 shares of ABT, increasing its weighting to 2.95% from 2.65% and 1,275 shares of GEHC, increasing its weighting to 3.25% from. The Trust will no longer own a position in BHC.

Many analysts think the market capitalization that has been lost from this overhang far exceeds what Abbott could ultimately pay to settle the cases, creating an opportunity to buy a Dividend Aristocrat on weakness. This will be our fourth Abbott buy since mid-March. GE Healthcare's first-quarter report on April 30 was not clean . We acknowledge that.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in BUSÄ°NESS

Business Business Latest News, Business Business Headlines